Small Cap Stock
Extreme Networks, Inc., together with its subsidiaries,
(collectively referred to as Extreme or the Company and as we , us and our ) is a leading provider of network infrastructure equipment for corporate, government, education and health care enterprises and metropolitan
telecommunications service providers. We were established in 1996 to address the issues caused by slow and ...
more
Plug Power Inc., together with its subsidiaries, is a development stage enterprise involved in the design, development and manufacture of on-site energy
systems for energy consumers worldwide. The Company is organized in the State of Delaware and was originally formed as a joint venture between Edison Development Corporation and Mechanical Technology Incorporated in the State of Delaware on ...
more
day of the registrant’s most recently completed second fiscal quarter
as reported by the NASDAQ National Market®, was approximately $40,680,752. In
calculating such aggregate market value, shares of common stock owned of record
or beneficially by officers, directors and persons known to the registrant to
own more than five percent of the registrant’s voting securities (other ...
more
We are a biopharmaceutical company that develops novel drugs for pain management and oncology. We have three investigational drug candidates in clinical
programs. Remoxy and PTI-202 are proprietary, abuse-resistant forms of opioid drugs. Oxytrex is a novel, next-generation painkiller that potentially offers less physical dependence than currently marketed opioid painkillers. We are also ...
more
We are a leader in powertrain engineering, system
integration, manufacturing and assembly of packaged fuel systems and accessories for specialty vehicles and applications including fuel cells, hybrids, alternative fuels, hydrogen refueling, new body styles, mid-cycle vehicle product enhancements
and high performance engines and drive trains for Original Equipment Manufacturers ...
more
VIVUS, Inc. is a pharmaceutical company dedicated
to the development and commercialization of therapeutic products for large
underserved markets using patented proprietary formulations and novel delivery
systems and by seeking new indications for previously approved pharmaceutical
products. We have employed this strategy and, currently, we have development
candidates addressing obesity, ...
more
Legal Proceedings
21
more
Private Business, Inc. is a leading provider of a full suite of technology-based products and services that help financial institutions remain competitive, serve their customers better, increase the efficiency of their operations, improve their competitive position in the marketplace, and boost their bottom-line profitability, while ...
more
